CARLCARLSMED, INC.同业对比
CARLSMED, INC. 与SIC 3841 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CARL本股 | $410M#8 | 136.6x#3 | 4.9x#7 | 8.1x#9 | 85.9%#3 | -22.2%#10 | -60.5%#11 | -35.2%#9 | -57.3%#8 | 5#4 | 16.1%#2 | — |
| SGHT | $521M#1 | — | 9.9x#10 | 6.7x#8 | -3.1%#10 | 25.4%#4 | -48.0%#9 | -72.6%#10 | -266.6%#9 | 5#4 | — | — |
| MDXG | $506M#2 | — | 2.4x#3 | 1.2x#3 | 20.0%#6 | 14.5%#8 | 15.3%#2 | 23.0%#1 | — | 7#2 | — | — |
| ANGO | $500M#3 | — | 3.0x#4 | 1.6x#4 | 9.5%#8 | -8.1%#9 | -12.5%#6 | -22.4%#6 | -15.7%#4 | 5#4 | — | — |
| DCTH | $497M#4 | 716.0x#4 | 4.1x#6 | 5.8x#7 | 129.1%#1 | 110.2%#1 | 0.8%#3 | 2.2%#2 | — | 8#1 | 45.6%#1 | — |
| SSII | $491M#5 | — | 9.2x#9 | 11.6x#11 | 105.7%#2 | 36.7%#2 | -19.3%#8 | -22.7%#7 | -20.1%#5 | — | — | — |
| CERS | $477M#6 | — | 6.3x#8 | 2.0x#5 | 16.1%#7 | 25.3%#5 | -3.7%#4 | -20.6%#4 | -13.7%#2 | — | — | — |
| NPCE | $422M#7 | — | 35.5x#11 | 4.2x#6 | 25.1%#5 | 20.9%#7 | -16.3%#7 | -180.6%#11 | -28.0%#7 | 4#8 | — | — |
| SI | $402M#9 | 0.1x#1 | 3.2x#5 | 8.5x#10 | 49.6%#4 | -158.4%#11 | -55.6%#10 | -32.5%#8 | -22.9%#6 | 3#9 | — | — |
| OFIX | $365M#10 | — | 0.8x#1 | 0.4x#2 | 2.9%#9 | 26.8%#3 | -9.9%#5 | -21.5%#5 | -14.9%#3 | 5#4 | — | — |
| MOBI | $361M#11 | — | 2.1x#2 | — | — | — | — | 0.0%#3 | — | — | — | — |
| EMBC | $352M#12 | 4.2x#2 | — | 0.3x#1 | -3.8%#11 | 21.8%#6 | 22.4%#1 | — | 27.0%#1 | 6#3 | — | 9.9%#1 |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议